Results 51 to 60 of about 35,054,180 (300)

An Open Science Peer Review Oath [PDF]

open access: yesF1000Research, 2015
One of the foundations of the scientific method is to be able to reproduce experiments and corroborate the results of research that has been done before. However, with the increasing complexities of new technologies and techniques, coupled with the specialisation of experiments, reproducing research findings has become a growing challenge.
Jelena Aleksic   +17 more
openaire   +7 more sources

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Advancing an Open Ethos with Open Peer Review

open access: yesCollege & Research Libraries, 2017
Open source. Open access. Open data. Open notebooks. Open government. Open educational resources. Open access workflows. To be open is to have a disposition favoring transparent and collaborative efforts.Open is everywhere. Since the late 90’s when developers in Silicon Valley adopted the term ‘open source’ (suggested by Christine Peterson), the open ...
openaire   +3 more sources

Peer Review of the Evidence Base

open access: yesEvidence Based Library and Information Practice, 2015
No abstract.
Lorie Kloda
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

The usability of open source software: analysis and prospects [PDF]

open access: yes, 2006
Open source communities have successfully developed many pieces of software although most computer users only use proprietary applications. The usability of open source software is often regarded as one reason for this limited distribution. In this paper
Nichols, David M., Twidale, Michael B.
core  

Open authoring and open review

open access: yes, 2007
Eric Mockensturm has launched a wiki, Open Source Publishing 2.0, outlining a proposal on which he is inviting collaboration. Excerpt: <strong> Update </strong> . Also see Eric's blog post about the proposal (June 18, 2007) and the comments it has generated.
openaire   +1 more source

Plankton in the open Mediterranean Sea: a review [PDF]

open access: yesBiogeosciences, 2009
Abstract. We present an overview of the plankton studies conducted during the last 25 years in the epipelagic offshore waters of the Mediterranean Sea. This quasi-enclosed sea is characterized by a rich and complex physical dynamics that includes unique thermohaline features, particular multilayer circulation, topographic gyres, and meso- and sub ...
Siokou Frangou, I.   +6 more
openaire   +5 more sources

Online Submission and Review System for Open Science: A Case of AccessON Peer Review Management System Plus (ACOMS+)

open access: yesJournal of Information Science Theory and Practice
As the academic publishing environment evolves rapidly and the open science paradigm emerges, the demand for efficient and transparent peer review is growing.
Jaemin Chung   +6 more
doaj   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy